3.3 Scientifically Validated, Proven Efficacy All processes undergo rigorous experimental validation to guarantee reliable outcomes: Precise amino acid precursor ratios: Glycine 12.64 mmol/L, Glutamic acid 6.30 mmol/L, Cysteine 3.72 mmol/L Optimal addition timing: Added 21 hours post-incubation for maximum synthesis efficiency Comprehensive performance enhancement: Simultaneously optimizes intracellular content, cell biomass, and total glutathione levels Value to You: Scientifically validated raw material performance provides robust data support for your product formulation's efficacy claims
Injection burden 2-3 injections per day on TB-500 days Best for Dose flexibility, injury-focused work Cycle driver GHK-Cu cycling typically sets the cycle length BPC-157 Loading 250-500 mcg/day (weeks 1-4) Frequency Daily Maintenance 250 mcg/day (weeks 5-8+) Route SubQ near injury or oral TB-500 Loading 2.5-5 mg per injection (weeks 1-4) Frequency 2x/week Maintenance 2 mg per injection (weeks 5-8+) Route SubQ systemic GHK-Cu Loading 1-2 mg/day (weeks 1-4) Frequency Daily Maintenance 1 mg/day (weeks 5-8+) Route SubQ Weekly Schedule Example Monday BPC-157 500 mcg + TB-500 2.5 mg + GHK-Cu 1-2 mg Tuesday BPC-157 500 mcg + GHK-Cu 1-2 mg Wednesday BPC-157 500 mcg + GHK-Cu 1-2 mg Thursday BPC-157 500 mcg + TB-500 2.5 mg + GHK-Cu 1-2 mg Friday BPC-157 500 mcg + GHK-Cu 1-2 mg Saturday BPC-157 500 mcg + GHK-Cu 1-2 mg Sunday BPC-157 500 mcg + GHK-Cu 1-2 mg Use a separate syringe for each compound
Although aging plays a major role in wound healing, it is often neglected in preclinical rodent models and clinical testing, resulting in a limited understanding of the mechanisms by which age slows healing (Gould et al., 2015)
While there's no official upper limit, doses up to 2,000 mcg can be safely used to treat B12 deficiency under medical supervision
Our IV treatments boast a 99.9% absorption rate, greatly surpassing the 8% typically offered by oral supplements
